These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 21986527)

  • 1. Key residues for the oligomerization of Aβ42 protein in Alzheimer's disease.
    Ngo S; Guo Z
    Biochem Biophys Res Commun; 2011 Oct; 414(3):512-6. PubMed ID: 21986527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer's Abeta42 peptide.
    Kim W; Hecht MH
    Proc Natl Acad Sci U S A; 2006 Oct; 103(43):15824-9. PubMed ID: 17038501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study.
    Lam AR; Teplow DB; Stanley HE; Urbanc B
    J Am Chem Soc; 2008 Dec; 130(51):17413-22. PubMed ID: 19053400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
    Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
    Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis.
    Wurth C; Guimard NK; Hecht MH
    J Mol Biol; 2002 Jun; 319(5):1279-90. PubMed ID: 12079364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
    Chang YJ; Chen YR
    FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligomerization and toxicity of Aβ fusion proteins.
    Caine JM; Bharadwaj PR; Sankovich SE; Ciccotosto GD; Streltsov VA; Varghese J
    Biochem Biophys Res Commun; 2011 Jun; 409(3):477-82. PubMed ID: 21600886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid β-Protein Assembly: Differential Effects of the Protective A2T Mutation and Recessive A2V Familial Alzheimer's Disease Mutation.
    Zheng X; Liu D; Roychaudhuri R; Teplow DB; Bowers MT
    ACS Chem Neurosci; 2015 Oct; 6(10):1732-40. PubMed ID: 26244608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenesis of the central hydrophobic cluster in Abeta42 Alzheimer's peptide. Side-chain properties correlate with aggregation propensities.
    de Groot NS; Aviles FX; Vendrell J; Ventura S
    FEBS J; 2006 Feb; 273(3):658-68. PubMed ID: 16420488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer's disease.
    El-Agnaf OM; Mahil DS; Patel BP; Austen BM
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1003-7. PubMed ID: 10891362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A plant cell-based system that predicts aβ42 misfolding: potential as a drug discovery tool for Alzheimer's disease.
    Zhao T; Zeng Y; Kermode AR
    Mol Genet Metab; 2012 Nov; 107(3):571-9. PubMed ID: 22944366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural origin of polymorphism of Alzheimer's amyloid β-fibrils.
    Agopian A; Guo Z
    Biochem J; 2012 Oct; 447(1):43-50. PubMed ID: 22823461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity.
    Yan Y; Wang C
    J Mol Biol; 2006 Dec; 364(5):853-62. PubMed ID: 17046788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's Aβ42 and Aβ40 form mixed oligomers with direct molecular interactions.
    Gu L; Guo Z
    Biochem Biophys Res Commun; 2021 Jan; 534():292-296. PubMed ID: 33272573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex situ atomic force microscopy analysis of beta-amyloid self-assembly and deposition on a synthetic template.
    Ha C; Park CB
    Langmuir; 2006 Aug; 22(16):6977-85. PubMed ID: 16863248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abeta40 protects non-toxic Abeta42 monomer from aggregation.
    Yan Y; Wang C
    J Mol Biol; 2007 Jun; 369(4):909-16. PubMed ID: 17481654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties.
    Sánchez L; Madurga S; Pukala T; Vilaseca M; López-Iglesias C; Robinson CV; Giralt E; Carulla N
    J Am Chem Soc; 2011 May; 133(17):6505-8. PubMed ID: 21486030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a proteolytically stable retro-inverso peptide inhibitor of beta-amyloid oligomerization as a potential novel treatment for Alzheimer's disease.
    Taylor M; Moore S; Mayes J; Parkin E; Beeg M; Canovi M; Gobbi M; Mann DM; Allsop D
    Biochemistry; 2010 Apr; 49(15):3261-72. PubMed ID: 20230062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.